Cargando…

C57BL/6N mice show a sub-strain specific resistance to the psychotomimetic effects of ketamine

Repeated administration of subanesthetic doses of ketamine is a model of psychosis-like state in rodents. In mice, this treatment produces a range of behavioral deficits, including impairment in social interactions and locomotion. To date, these phenotypes were described primarily in the Swiss and C...

Descripción completa

Detalles Bibliográficos
Autores principales: Harda, Zofia, Misiołek, Klaudia, Klimczak, Marta, Chrószcz, Magdalena, Rodriguez Parkitna, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731130/
https://www.ncbi.nlm.nih.gov/pubmed/36505728
http://dx.doi.org/10.3389/fnbeh.2022.1057319
_version_ 1784845842295816192
author Harda, Zofia
Misiołek, Klaudia
Klimczak, Marta
Chrószcz, Magdalena
Rodriguez Parkitna, Jan
author_facet Harda, Zofia
Misiołek, Klaudia
Klimczak, Marta
Chrószcz, Magdalena
Rodriguez Parkitna, Jan
author_sort Harda, Zofia
collection PubMed
description Repeated administration of subanesthetic doses of ketamine is a model of psychosis-like state in rodents. In mice, this treatment produces a range of behavioral deficits, including impairment in social interactions and locomotion. To date, these phenotypes were described primarily in the Swiss and C3H/HeHsd mouse strains. A few studies investigated ketamine-induced behaviors in the C57BL/6J strain, but to our knowledge the C57BL/6N strain was not investigated thus far. This is surprising, as both C57BL/6 sub-strains are widely used in behavioral and neuropsychopharmacological research, and are de facto standards for characterization of drug effects. The goal of this study was to determine if C57BL/6N mice are vulnerable to develop social deficits after 5 days withdrawal from sub-chronic ketamine treatment (5 days, 30 mg/kg, i.p.), an experimental schedule shown before to cause deficits in social interactions in C57BL/6J mice. Our results show that sub-chronic administration of ketamine that was reported to cause psychotic-like behavior in C57BL/6J mice does not induce appreciable behavioral alterations in C57BL/6N mice. Thus, we show that the effects of sub-chronic ketamine treatment in mice are sub-strain specific.
format Online
Article
Text
id pubmed-9731130
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97311302022-12-09 C57BL/6N mice show a sub-strain specific resistance to the psychotomimetic effects of ketamine Harda, Zofia Misiołek, Klaudia Klimczak, Marta Chrószcz, Magdalena Rodriguez Parkitna, Jan Front Behav Neurosci Neuroscience Repeated administration of subanesthetic doses of ketamine is a model of psychosis-like state in rodents. In mice, this treatment produces a range of behavioral deficits, including impairment in social interactions and locomotion. To date, these phenotypes were described primarily in the Swiss and C3H/HeHsd mouse strains. A few studies investigated ketamine-induced behaviors in the C57BL/6J strain, but to our knowledge the C57BL/6N strain was not investigated thus far. This is surprising, as both C57BL/6 sub-strains are widely used in behavioral and neuropsychopharmacological research, and are de facto standards for characterization of drug effects. The goal of this study was to determine if C57BL/6N mice are vulnerable to develop social deficits after 5 days withdrawal from sub-chronic ketamine treatment (5 days, 30 mg/kg, i.p.), an experimental schedule shown before to cause deficits in social interactions in C57BL/6J mice. Our results show that sub-chronic administration of ketamine that was reported to cause psychotic-like behavior in C57BL/6J mice does not induce appreciable behavioral alterations in C57BL/6N mice. Thus, we show that the effects of sub-chronic ketamine treatment in mice are sub-strain specific. Frontiers Media S.A. 2022-11-24 /pmc/articles/PMC9731130/ /pubmed/36505728 http://dx.doi.org/10.3389/fnbeh.2022.1057319 Text en Copyright © 2022 Harda, Misiołek, Klimczak, Chrószcz and Rodriguez Parkitna. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Harda, Zofia
Misiołek, Klaudia
Klimczak, Marta
Chrószcz, Magdalena
Rodriguez Parkitna, Jan
C57BL/6N mice show a sub-strain specific resistance to the psychotomimetic effects of ketamine
title C57BL/6N mice show a sub-strain specific resistance to the psychotomimetic effects of ketamine
title_full C57BL/6N mice show a sub-strain specific resistance to the psychotomimetic effects of ketamine
title_fullStr C57BL/6N mice show a sub-strain specific resistance to the psychotomimetic effects of ketamine
title_full_unstemmed C57BL/6N mice show a sub-strain specific resistance to the psychotomimetic effects of ketamine
title_short C57BL/6N mice show a sub-strain specific resistance to the psychotomimetic effects of ketamine
title_sort c57bl/6n mice show a sub-strain specific resistance to the psychotomimetic effects of ketamine
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731130/
https://www.ncbi.nlm.nih.gov/pubmed/36505728
http://dx.doi.org/10.3389/fnbeh.2022.1057319
work_keys_str_mv AT hardazofia c57bl6nmiceshowasubstrainspecificresistancetothepsychotomimeticeffectsofketamine
AT misiołekklaudia c57bl6nmiceshowasubstrainspecificresistancetothepsychotomimeticeffectsofketamine
AT klimczakmarta c57bl6nmiceshowasubstrainspecificresistancetothepsychotomimeticeffectsofketamine
AT chroszczmagdalena c57bl6nmiceshowasubstrainspecificresistancetothepsychotomimeticeffectsofketamine
AT rodriguezparkitnajan c57bl6nmiceshowasubstrainspecificresistancetothepsychotomimeticeffectsofketamine